4.6 Article

Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

Gareth Maher-Edwards et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)

Article Neurosciences

Multiple models to capture the variability in biological neurons and networks

Eve Marder et al.

NATURE NEUROSCIENCE (2011)

Review Neurosciences

How Inhibition Shapes Cortical Activity

Jeffry S. Isaacson et al.

NEURON (2011)

Article Clinical Neurology

Disease progression meta-analysis model in Alzheimer's disease

Kaori Ito et al.

ALZHEIMERS & DEMENTIA (2010)

Article Clinical Neurology

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease

G. Maher-Edwards et al.

CURRENT ALZHEIMER RESEARCH (2010)

Article Clinical Neurology

Current Alzheimer's disease clinical trials: Methods and placebo outcomes

Lon S. Schneider et al.

ALZHEIMERS & DEMENTIA (2009)

Article Psychiatry

Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia

Oliver D. Howes et al.

ARCHIVES OF GENERAL PSYCHIATRY (2009)

Article Mathematical & Computational Biology

Computational disease modeling - fact or fiction?

Jesper N. Tegner et al.

BMC SYSTEMS BIOLOGY (2009)

Article Medicine, General & Internal

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial

Robert C. Green et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Neurosciences

Neural Dynamics in Inferior Temporal Cortex during a Visual Working Memory Task

Luke Woloszyn et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Neurosciences

Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine

Shawn E. Kotermanski et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Neurosciences

Dopamine modulates an mGluR5-mediated depolarization underlying prefrontal persistent activity

Kyriaki Sidiropoulou et al.

NATURE NEUROSCIENCE (2009)

Article Pharmacology & Pharmacy

Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection

S. D. Buckingham et al.

PHARMACOLOGICAL REVIEWS (2009)

Review Pharmacology & Pharmacy

Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders

P. Jeffrey Conn et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2009)

Review Behavioral Sciences

The role of 5-HT1A receptors in learning and memory

Sven Ove Ogren et al.

BEHAVIOURAL BRAIN RESEARCH (2008)

Article Clinical Neurology

Functional consequences of locus coeruleus degeneration in Alzheimer's disease

David Weinshenker

CURRENT ALZHEIMER RESEARCH (2008)

Article Neurosciences

Parvalbumin-positive basket interneurons in monkey and rat prefrontal cortex

N. V. Povysheva et al.

JOURNAL OF NEUROPHYSIOLOGY (2008)

Article Biochemistry & Molecular Biology

Selective loss of synaptic proteins in Alzheimer's disease:: Evidence for an increased severity with APOE ε4

Rudi K. Tannenberg et al.

NEUROCHEMISTRY INTERNATIONAL (2006)

Article Geriatrics & Gerontology

Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial

Elaine R. Peskind et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)

Article Neurosciences

Low doses of memantine disrupt memory in adult rats

C Creeley et al.

JOURNAL OF NEUROSCIENCE (2006)

Review Cell Biology

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease

A Lanari et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2006)

Article Neurosciences

Cholinergic inhibition of neocortical pyramidal neurons

AT Gulledge et al.

JOURNAL OF NEUROSCIENCE (2005)

Article Clinical Neurology

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease

NI Bohnen et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Article Neurosciences

Dynamic gain control of dopamine delivery in freely moving animals

PR Montague et al.

JOURNAL OF NEUROSCIENCE (2004)

Article Pharmacology & Pharmacy

Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release

LF Zhang et al.

MOLECULAR PHARMACOLOGY (2004)

Review Neurosciences

Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro

RD Traub et al.

ANNUAL REVIEW OF NEUROSCIENCE (2004)

Article Clinical Neurology

New Insights into Serotonin 5-HT4 Receptors: A Novel Therapeutic Target for Alzheimer's Disease?

Marjorie Maillet et al.

CURRENT ALZHEIMER RESEARCH (2004)

Article Medicine, General & Internal

Memantine in moderate-to-severe Alzheimer's disease

B Reisberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Medicine, General & Internal

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors

S Gauthier et al.

CURRENT MEDICAL RESEARCH AND OPINION (2003)

Article Pharmacology & Pharmacy

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease

V Kaasinen et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)

Article Geriatrics & Gerontology

APOE genotype:: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease

J Aerssens et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2001)

Article Neurosciences

Segregation of working memory functions within the dorsolateral prefrontal cortex

R Levy et al.

EXPERIMENTAL BRAIN RESEARCH (2000)